ClinicalTrials.Veeva

Menu

A Single Preoperative Dose of Gabapentin to Decreases Postoperative Pain in Ambulatory Anal Surgeries

M

Minia University

Status and phase

Completed
Early Phase 1

Conditions

Pain, Postoperative

Treatments

Drug: Gabapentin

Study type

Interventional

Funder types

Other

Identifiers

NCT05533684
343-2022

Details and patient eligibility

About

Single dose 600 mg gabapentin will be given preoperatively in anal surgeries

Full description

Patients will be grouped into 2 groups of 25 patients each, the first group will receive 600 mg of gabapentin one hour before surgery and the second group will receive a placebo tablet. pain scores will be measured postoperatively

Enrollment

50 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. ASA physical status I or II
  2. Aged from 18 to 65 years
  3. Scheduled for anal surgeries at Minya University Hospital

Exclusion criteria

  1. Presence of contraindications to neuraxial anesthesia
  2. Presence of history of central nervous system or mental disorders, epilepsy, chronic pain, or drug abuse.
  3. The use of neuropathic analgesic or antiepileptic drugs

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

50 participants in 2 patient groups

postoperative pain
No Intervention group
Description:
Measuring postoperative pain using the visual analogue scale
total analgesic consumption
Other group
Description:
Recording the total amount of analgesia consumed by the patients
Treatment:
Drug: Gabapentin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems